High affinity binding of tricyclic antidepressants to histamine H1-receptors: Fact and artifact

John E. Taylor, Elliott Richelson

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Six tricyclic antidepressants were tested for their ability to inhibit the binding of the histamine H1-receptor antagonist [3H]pyrilamine to membrane fractions from whole rat brain. Calculated inhibition constants (Ki) for the antidepressants were in the range of 2.6 × 10−11 to 2.3 × 10−7M and correlated very well with their equilibrium dissociation constants derived from biological assays of the H1-receptor. Increasing the concentration of receptors present in the binding assay resulted in an overestimation of the calculated Ki's for doxepin, amitriptyline, and nortriptyline, but not for the lower affinity compounds of the series, imipramine, protriptyline, and desipramine. These results indicate: (1) the importance of receptor concentration in determining the potency of compounds which competitively inhibit, with very high affinity, the binding of a radioactively labeled ligand; (2) the need to correlate binding data with biological data.

Original languageEnglish (US)
Pages (from-to)41-46
Number of pages6
JournalEuropean Journal of Pharmacology
Volume67
Issue number1
DOIs
StatePublished - 1980

Keywords

  • Histamine H-receptor
  • Tricyclic antidepressants

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'High affinity binding of tricyclic antidepressants to histamine H<sub>1</sub>-receptors: Fact and artifact'. Together they form a unique fingerprint.

Cite this